Trials / Completed
CompletedNCT04642820
Drugs Brain and Behavior (DDP)
Drugs Brain and Behavior
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
In this project, we will examine individual differences in the effects of a stimulant drug, methamphetamine (MA), on mesolimbic reward function using fMRI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methamphetamine | Participants will be given 20 mg of Methamphetamine. |
| DRUG | placebo oral tablet | Participants will be given a placebo capsule that will only contain lactose. |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2023-10-01
- Completion
- 2024-06-01
- First posted
- 2020-11-24
- Last updated
- 2025-01-09
- Results posted
- 2025-01-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04642820. Inclusion in this directory is not an endorsement.